Global Frequency, Diagnosis, and Treatment of Hereditary Angioedema with Normal C1 Inhibitor
Healthcare Utilization and Costs Among Hereditary Angioedema Patients Receiving Long-Term Prophylaxis: Results of a Claims Database Analysis
Barriers to Timely On-Demand Treatment of Hereditary Angioedema Attacks in Italian Patients
Indirect Treatment Comparison of Oral Sebetralstat and Intravenous Recombinant Human C1 Esterase Inhibitor for On-demand Treatment of Hereditary Angioedema Attacks
Barriers to Timely On-Demand Treatment of Hereditary Angioedema Attacks in Italian Patients
Burden of Injectable On-Demand Treatment for Hereditary Angioedema Attacks in Adolescents
Delays in the On-Demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported in Different Healthcare Systems
Study to Adjudicate Hereditary Angioedema with Normal C1INH Diagnoses in the PIONEER-HAE Database
Impact of Long-Term Prophylaxis Adherence in Hereditary Angioedema Patients: Results of a Claims Database Analysis
Impact of Delayed Treatment of Hereditary Angioedema Attacks on Quality of Life and Ability to Work
Impact of Hereditary Angioedema Attacks on Quality of Life and Ability to Work Among UK Patients Receiving Long-term Prophylaxis or On-demand Only
On-demand Treatment of Hereditary Angioedema Attacks: Patient-reported Utilization, Barriers, and Outcomes
Patient-Reported Anxiety Impacts Utilization of Injectable On-demand Treatment of Hereditary Angioedema Attacks
Real World Barriers to On-Demand Treatment for Attacks in Hereditary Angioedema: A Patient Survey
Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks
Global Frequency and Diagnosis of Hereditary Angioedema with Normal C1INH: A Real World ACARE Survey
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Italian Patient Perceptions and Associated Barriers
A Specific, Sensitivity Assay Measuring Patient Sample Plasma Kallikrein Activity
Delayed On-demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported by Italian Patients
Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-demand Treatment
The Complexities of Decision-Making Associated with On-Demand Treatment of Hereditary Angioedema (HAE) Attacks
Anxiety Associated with On-demand Treatment of Hereditary Angioedema (HAE) Attacks
Attack Characteristics in Patients with Hereditary Angioedema Receiving Non-Androgen Long-term Prophylaxis
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers
Hereditary Angioedema (HAE) Patients Answer: Why Do Attacks Go Untreated?
Patient-Reported Benefits of Early On-Demand Treatment of HAE Attacks
Treatment of HAE Attacks with Anticipated Future Oral On-Demand Therapies as Reported by Patients
Unmet Needs Associated with Non-androgen Injectable Long-term Prophylaxis (LTP) Therapies for HAE
Burden of Untreated Hereditary Angioedema Attacks and its Impact on Social, Mental, and Physical Health
Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis
Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity
Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life
Trends in Volume of On-demand Hereditary Angioedema Treatments in the US: A Retrospective Analysis of a Large Multi-payer Claims Database
Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis
Relationship Between Time to On-demand Treatment and Quality of Life During Hereditary Angioedema Attacks
Anxiety Associated with On-demand Treatment of Hereditary Angioedema (HAE) Attacks
Anxiety Associated with Refilling On-demand Therapy for HAE Attacks Contributes to Treatment Delay and Non-Treatment
Characteristics of Hereditary Angioedema Attacks Among Long-term Prophylaxis Users
Characterizing the Negative Impact of Delayed On-Demand Treatment of HAE Attacks
Characterizing the Perspectives of Patients with HAE on Prophylactic Treatment
Delayed Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers
The Impact of On-demand Treatment on Quality of Life of People with HAE
Burden of Hereditary Angioedema Attacks in Adolescents
Quality of Life Among Prophylaxis Plus On-Demand and On-Demand Only Therapy Users in HAE
Real-world Reporting Rates of Administration-site Reactions with On-demand Treatment of Hereditary Angioedema Attacks
Anxiety Associated with On-demand Treatment of Hereditary Angioedema (HAE) Attacks May Result in Sub-optimal Attack Management
Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them
Reporting of Administration Site Reactions with Parenteral Drugs for the On-demand Treatment of Hereditary Andioedema Attacks – Analysis of the FAERS Database 2009 – 2022
The Discovery of Sebetralstat, an Oral, Small Molecule Plasma Kalkrein Inhibitor to Treat Attacks of Hereditary Angioedema
Hereditary Angioedema with Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns
In Their Own Words – Patients Descriptions of the Earliest Recognition of Hereditary Angioedema Attack Onset
Preferences of People with Hereditary Angioedema for On-demand Treatment: A US Based Qualitative Study
Recognizing the Importance of Early On-demand Treatment in the Hereditary Angioedema (HAE) Attack Journey
Patients Delay Treating Hereditary Angioedema (HAE) Attacks with Currently Available, Injectable, On-demand Therapies
Remaining Burden of Hereditary Angioedema (HAE) Attacks Despite Modern Long-term Prophylaxis
Understanding the Complex Decision-Making Associated with On-Demand Treatment of Hereditary Angioedema (HAE) Attacks
HAE Patients’ Decision to Carry On-demand Treatment When Away from Home
Route of Administration Preferences of People Living with Hereditary Angioedema for On-demand Treatment: A US Based Qualitative Study
Anxiety Associated With Parenteral On-demand Treatment For Hereditary Angioedema (HAE)
Targeted Literature Review to Assess the Studies Supporting Short-term Prophylactic Treatment Options for the Preprocedural Prevention of Attacks in Patients with Hereditary Angioedema
